SCHEMBL4691401

SCHEMBL4691401

O=C(CCOC(=O)N(c1ccccc1-c1ccccc1)N1CC[CH]CC1)Nc1ccc(CNCc2ccncc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.41
DRD2 P14416 4/20 0.41
HTR7 P34969 3/20 0.41
HTR6 P50406 2/20 0.41
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 2/20 0.38
NAMPT P43490 2/20 0.37
NPY5R Q15761 1/20 0.37
LMNA P02545 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
RECQL P46063 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 1/20 0.35
EPHX1 P07099 1/20 0.35
HTT P42858 1/20 0.34
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6021982 0.92 ALDH1A1 (0.39) ALDH1A1LMNARECQLTSHRMAPT
SCHEMBL6021981 0.87 RECQL (0.34) HTR1ADRD2HTR7HTR6ALDH1A1
SCHEMBL6021934 0.86 MEN1 (0.40) ALDH1A1RECQLTSHRMAPT
SCHEMBL4691523 0.86 TPSAB1 (0.36) ALDH1A1NAMPTTSHRMAPT
SCHEMBL6027475 0.77 TRPV1 (0.37) HTR1ADRD2HTR7HTR6KDM4E
SCHEMBL4695551 0.76 CNR2 (0.40) HTR1ADRD2HTR7HTR6KDM4E
SCHEMBL6021999 0.75 LTB4R2 (0.33) HTR1ADRD2HTR7HTR6ALDH1A1
SCHEMBL3726076 0.75 CHRM3 (0.37)
SCHEMBL5279260 0.75 ALDH1A1 (0.41) ALDH1A1KDM4EL3MBTL1TSHRMAPK1
SCHEMBL6021946 0.74 TRPV1 (0.47) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP disclosed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO disclosed